What is NeuroBlate®?

Home Patients & Caregivers What is NeuroBlate®?

Minimally Invasive Robotic Laser Thermotherapy

The NeuroBlate® laser ablation system enables doctors to destroy brain lesions with precision and confidence.

Learn more about the procedure today.


How does the NeuroBlate System work?

With NeuroBlate, the surgeon attempts to ablate lesions in the brain. Unlike traditional brain surgery, a procedure with the NeuroBlate System does not require a large opening in the skull. Instead, doctors create a small hole in the skull, about the diameter of a pencil.  While the patient is in the MRI machine, the doctor guides a small laser device (probe) through the hole into the lesion. The probe delivers laser light energy that heats and destroys the affected tissue. Because the NeuroBlate System is MRI-guided, the neurosurgeon is able to visualize the specific area of the brain to be ablated. The precise nature of the procedure helps to lessen the likelihood of harm to nearby healthy brain tissue.1,2,3,4

What will I experience right before and after the ablation with the NeuroBlate System?

You will receive anesthesia before the procedure. Your doctor will determine what level of anesthesia is right for you. After the procedure, you will have a stitch or two in the skin where the probe was inserted. You may also have scratches on your head from the device that held your head in position.

How soon after the procedure can I go home from the hospital?

Experience shows that patients generally tolerate the procedure well, but each patient is different.

Minimally Invasive Intra-op

NeuroBlate is a minimally invasive surgery, a type requiring only a small opening in the body instead of a large incision as in open surgery.

Minimally Invasive Post-op

Minimally invasive procedures are generally well tolerated, have a short recovery time and patients go home with 1-2 stitches.

What outlook can I expect after a procedure with the NeuroBlate System?

Each patient is unique. Your doctors are the best qualified to describe specifically how a procedure may affect your outlook.

What are the risks related to procedures using the NeuroBlate System?

Monteris devices are used by neurosurgeons, which allows them to hold the patient’s head steady while in an MRI machine and during brain surgery, to allow minimally invasive and stable access for brain probes, and to heat and destroy targeted tissue. Patients must be able to undergo MRI exposure.

All brain surgeries carry risk. Possible adverse events include, but are not limited to, bleeding, edema, unintended major brain tissue damage, and permanent neurological deficits. Discuss with your physician the potential benefits and risks.

Rx Only.

NeuroBlate System. Patient Brochure


Monteris provides technology for neurosurgeons, which allows them to ablate (destroy with lethal heat) from the inside, brain lesions and brain tumors that may be difficult to approach via traditional methods. Technology includes the NeuroBlate System, AxiiiS, AtamA, and MiniBolt devices, which may be used together to apply the focused laser energy with little or no effect on surrounding healthy tissue. The NeuroBlate System provides clinicians a tool that offers near real-time control and MRI visualization of the therapy during laser ablation treatment.

All brain surgeries carry risk. Possible adverse events include, but are not limited to, hematoma, embolic events, edema, bleeding, cerebral spinal fluid (CSF) leakage, infection, unintended major tissue damage and permanent neurological deficits. Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.

Rx Only.

  1. Wilson TA, Karajannis MA, and Harter DH. Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int. 2014 May 8;5:64.
  2. Mohammadi AM and Schroeder JL. Laser interstitial thermal therapy in treatment of brain tumors – the NeuroBlate System. Expert Review of Medical Devices 2014 11:2, 109-119.
  3. Sloan AE, Ahluwalia MS, Valerio-Pascua J, et al. Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg. 2013 Jun;118(6):1202-19.
  4. Carpentier A, McNichols RJ, Stafford RJ, et al. Laser thermal therapy: real-time MRI-guided and computer- controlled procedures for metastatic brain tumors. Lasers Surg Med. 2011 Dec;43(10):943-50.